Key | % Net Assets |
---|---|
BP | 8.2% |
Vodafone | 6.2% |
AstraZeneca | 5.8% |
Royal Dutch Shell | 5.6% |
Other | 74.2% |
Name | % Net Assets |
---|---|
BP | 8.2% |
Vodafone | 6.2% |
AstraZeneca | 5.8% |
Royal Dutch Shell | 5.6% |
Imperial Tobacco | 4.3% |
British American Tobacco | 3.4% |
ICAP | 3.1% |
Sanofi-Aventis | 2.7% |
Diageo | 2.5% |
Provident Financial | 2.2% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 103.62p |
Currency | GBP |
Change | -0.060p |
% | -0.06% |
YTD change | 2.82p |
YTD % | 2.80% |
Fund Inception | 12/02/1996 |
---|---|
Fund Manager | n/a |
TER | 1.81 (31-Oct-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.14 |
You are here: research